Research records indexed for Triptorelin
This page carries 12 of the 1,047 records that the literature query returned for Triptorelin, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 1,035 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Triptorelin.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy pmid:26729437 | 2016 | research-article, Randomized Controlled Trial | human trial | Not stated | Indexed as research-article, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Ovary; Breast Neoplasms; Tamoxifen; Androstadienes; Estradiol. |
| Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial pmid:26720025 | 2015 | Clinical Trial, Phase III, Research Support, Non-U.S. Gov't | human trial | Not stated | Indexed as clinical trial, phase iii, research support, non-u.s. gov't. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Ovary; Breast Neoplasms; Luteolytic Agents; Antineoplastic Agents, Hormonal; Disease-Free Survival. |
| Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer pmid:22231041 | 2012 | research-article, Randomized Controlled Trial | human trial | Not stated | Indexed as research-article, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Ovary; Breast Neoplasms; Amenorrhea; Paclitaxel; Tamoxifen. |
| Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial pmid:21771987 | 2011 | Clinical Trial, Phase III, Research Support, Non-U.S. Gov't | human trial | Not stated | Indexed as clinical trial, phase iii, research support, non-u.s. gov't. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Breast Neoplasms; Infertility, Female; Cisplatin; Tamoxifen; Fluorouracil. |
| A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis pmid:20661580 | 2011 | Comparative Study, Randomized Controlled Trial | human trial | Not stated | Indexed as comparative study, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Endometriosis; Infertility, Female; Nitriles; Triazoles; Aromatase Inhibitors. |
| Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial pmid:21693037 | 2011 | research-article, Randomized Controlled Trial | human trial | Not stated | Indexed as research-article, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Endometriosis; Dyspareunia; Pelvic Pain; Nitriles; Triazoles. |
| A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status pmid:19135657 | 2010 | Comparative Study, Multicenter Study | human trial | Not stated | Indexed as comparative study, multicenter study. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Leiomyoma; Uterine Neoplasms; Hot Flashes; Nitriles; Triazoles. |
| Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study pmid:19888782 | 2009 | Clinical Trial, Phase III, Multicenter Study | human trial | Not stated | Indexed as clinical trial, phase iii, multicenter study. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Prostatic Neoplasms; Neoplasm Metastasis; Hot Flashes; Testosterone; Prostate-Specific Antigen. |
| Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer pmid:12887472 | 2003 | Comparative Study, Clinical Trial | human trial | Not stated | Indexed as comparative study, clinical trial. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Prostatic Neoplasms; Testosterone; Leuprolide; Analgesics; Antineoplastic Agents, Hormonal. |
| Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study pmid:11937116 | 2002 | Clinical Trial, Phase III, Clinical Trial | human trial | Not stated | Indexed as clinical trial, phase iii, clinical trial. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Endometriosis; Cholesterol; Nandrolone; Hormone Antagonists; Alkaline Phosphatase. |
| Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation pmid:11278211 | 2001 | Comparative Study, Clinical Trial | human trial | Not stated | Indexed as comparative study, clinical trial. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Ovary; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Estradiol; Hormone Antagonists. |
| Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin) pmid:10685535 | 2000 | Comparative Study, Clinical Trial | human trial | Not stated | Indexed as comparative study, clinical trial. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Oocytes; Estradiol; Hormone Antagonists; Luteinizing Hormone; Luteolytic Agents. |
Where this page sits
Compound page: Triptorelin. Class: Endocrine and immune signalling peptides.
Retrieved 2026-10-12.
Sources
- PubChem Compound Summary for CID 25074470, Triptorelin. PubChem, National Library of Medicine (2026). pubchem:25074470
- Drugs@FDA application register query for this compound, 4 application(s) returned: NDA021288, NDA020715, NDA208956, NDA022437. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:triptorelin
- Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer. BJU international (2003). pmid:12887472
- Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty. The Journal of clinical endocrinology and metabolism (1999). pmid:10372696
- Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertility and sterility (2000). pmid:10685535
- Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. Human reproduction (Oxford, England) (2000). pmid:10966996
- Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Human reproduction (Oxford, England) (2001). pmid:11278211
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertility and sterility (2002). pmid:11937116
- A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertility and sterility (2010). pmid:19135657
- Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA (2011). pmid:21771987
- Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2012). pmid:22231041
- Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial. JAMA (2015). pmid:26720025
- Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2016). pmid:26729437
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.